Medi Assist Healthcare Services Ltd reported strong consolidated performance for 9MFY26, underpinned by revenue growth, balance-sheet strengthening, and technology-driven efficiencies. Total income rose 23.5% YoY to ₹680 crore, while revenue from contracts grew 24% YoY to ₹662.8 crore. EBITDA stood at ₹126.3 crore, with margins at 19.1%. The company achieved a major milestone by turning debt-free in January 2026, sharply reducing debt from ₹243.4 crore (Sep’25) to ₹39.4 crore (Dec’25) and maintaining a free cash position of ₹200.1 crore.
Operationally, Premium Under Management expanded 21.9% YoY to ₹19,289 crore, while overall Group + Retail market share improved to 21.1% (+133 bps) and Group share rose to 32.2% (+307 bps). The company now serves 39+ crore lives annually and processed 72.9 lakh claims, reflecting 22.4% growth.
Paramount Integration Progress
Integration of Paramount is advancing with technology consolidation and AI deployment across clients. The slump transfer of Paramount TPA business became effective February 1, 2026, accelerating synergies. Paramount standalone EBITDA margins improved 557 bps QoQ, indicating operational stabilization.
Segment and Technology Momentum
Growth remained broad-based: Group PUM rose 24.2%, Retail PUM 26.5%, Government revenue grew 45.9% in Q3, and International Benefits Administration expanded 16.3% YoY. The technology segment remained a key differentiator, with proprietary tech revenue rising 81.5% YoY. Fraud detection platform MAven Guard identified nearly ₹400 crore fraud, while Raksha Prime and MAven Navigator enhanced the cashless healthcare experience.
Other Corporate Updates
Radiant Cash Management Services Ltd will hold its Q3FY26 earnings conference call on February 12, 2026, with senior leadership discussing financial performance and outlook.
Cipla Ltd confirmed the conclusion of a GST Department inspection in Maharashtra on February 7, 2026, stating there is no material impact on financials or operations.
Godrej Agrovet launched ‘TAKAI’ insecticide for rice crops, powered by Cyclapryn technology from ISK Japan, targeting major pests such as Stem Borer and Leaf Folder. The product aims to improve crop yield and is also seeking approvals for multiple crops including maize, soybean, and sugarcane.
Global Market Snapshot (Feb 9, 2026)
Global equities remained firm. Dow Jones Futures rose 0.25%, while S&P 500 gained 1.97% and Nasdaq climbed 2.25%. In Asia, GIFT Nifty advanced 0.94% and Nikkei surged 4.75%, though Hang Seng (-1.22%) and Shanghai Composite (-0.25%) declined.
